Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04812054
What this trial is testing

Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death

Who this might be right for
Liver CirrhosisLiver TumorLiver Transplant Failure and Rejection
Medical University of Warsaw 104
Post-approval studies (Phase 4)UnknownNCT02281266
What this trial is testing

Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection

Who this might be right for
Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
Jia Fan 360
Not applicableActive Not RecruitingNCT01796145
What this trial is testing

Fibroscan Study in HCC

Who this might be right for
Confirmed Diagnosis of Hepatocellular CarcinomaPatients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy SurgeryChild's A to C Cirrhosis
Chinese University of Hong Kong 207
Early research (Phase 1)Looking for participantsNCT05003895
What this trial is testing

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma
National Cancer Institute (NCI) 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07668570
What this trial is testing

SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Hebei Medical University Fourth Hospital 36
Not applicableActive Not RecruitingNCT06934070
What this trial is testing

Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC) Prognosis
Qiang Xu 287
Not applicableStudy completedNCT00883454
What this trial is testing

Estimation of Functional Liver Reserve Using Cholinesterases

Who this might be right for
Hepatocellular CarcinomaCirrhosisLiver Neoplasm+1 more
University of Milan 181
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Not applicableUnknownNCT05557656
What this trial is testing

A Real World Study of Regogfinib in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 800
Large-scale testing (Phase 3)WithdrawnNCT02527772
What this trial is testing

Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Testing effectiveness (Phase 2)Study completedNCT00777894
What this trial is testing

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Swiss Cancer Institute 18
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03963037
What this trial is testing

Characterization of Two Novel Mutations in the Apob Gene

Who this might be right for
Familial Hypobetalipoproteinaemia - Heterozygous FormLow-LDL-syndrome
Medical University Innsbruck 16
Not applicableStudy completedNCT00132041
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
American College of Radiology Imaging Network 51
Not applicableEnded earlyNCT04258566
What this trial is testing

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Who this might be right for
Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC) 7
Not applicableStudy completedNCT02670122
What this trial is testing

Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 131
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07119931
What this trial is testing

A Clinical Study Evaluating HAIC Combined With Iparomlimab and Tuvonralimab Injection Plus Bevacizumab in Patients With Initially Potentially Resectable Hepatocellular Carcinoma (ITBHaic Study)

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06280105
What this trial is testing

A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

Who this might be right for
Hepatocellular Carcinoma
Meng Chao Hepatobiliary Hospital of Fujian Medical University 40
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Next Page